| |
| |
|
| Insider
Information: |
Cheng Sohanya Roshan |
| Relationship: |
|
| City: |
Newton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
393,509 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$424,990 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
393,509 |
|
|
| Total
Value |
$424,990 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Karyopharm Therapeutics Inc. |
KPTI |
|
2024-03-01 |
393,509 |
2021-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KPTI |
Karyopharm Therapeutics I... |
EVP & Chief Commercial Officer |
• – – |
2024-03-01 |
4 |
S |
$1.20 |
$6,131 |
D/D |
(5,109) |
393,509 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP & Chief Commercial Officer |
• – – |
2024-02-29 |
4 |
S |
$1.17 |
$25,553 |
D/D |
(21,840) |
398,618 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP & Chief Commercial Officer |
• – – |
2024-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
198,959 |
420,458 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP & Chief Commercial Officer |
• – – |
2024-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
14,167 |
221,499 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP & Chief Commercial Officer |
• – – |
2023-09-01 |
4 |
S |
$1.33 |
$9,872 |
D/D |
(7,415) |
204,086 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP & Chief Commercial Officer |
• – – |
2023-06-08 |
4 |
S |
$2.35 |
$4,322 |
D/D |
(1,839) |
211,501 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP & Chief Commercial Officer |
• – – |
2023-03-01 |
4 |
S |
$3.03 |
$34,045 |
D/D |
(11,239) |
210,687 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP & Chief Commercial Officer |
• – – |
2023-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
221,926 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP & Chief Commercial Officer |
• – – |
2022-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
119,949 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
Chief Commercial Officer |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
84,000 |
91,500 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP Sales & Commercial Ops |
• – – |
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
7,500 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
